Real-time enrollment status for this schizophrenia clinical trial
Current Status
Recruiting
Checked: October 17, 2026 at 4:48 PM UTC
| NCT Number | NCT06229210 |
| Recruiting Status | Recruiting |
| Condition | Schizophrenia |
| Phase | PHASE3 |
| Target Enrollment | 300 participants |
| Active Locations | 59 sites in the US |
| Sponsor | Intra-Cellular Therapies, Inc. |
| Last Updated on CT.gov | September 25, 2026 (3 weeks ago) |
As of October 17, 2026: Clinical trial NCT06229210 is currently recruiting participants. This phase3 study for schizophrenia is actively seeking new participants at 59 locations across the United States. The study is sponsored by Intra-Cellular Therapies, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06229210 is actively recruiting participants as of October 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 59 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06229210 was last updated 3 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.